Immunotherapy Drug, Avelumab, Boosts Survival With Bladder Cancer
MONDAY, Sept. 21, 2020 — An immunotherapy drug significantly improved survival in patients with the most common type of bladder
Read more
MONDAY, Sept. 21, 2020 — An immunotherapy drug significantly improved survival in patients with the most common type of bladder
Read moreStimulating immune cells with two cancer immunotherapies together can shrink the size of the viral “reservoir” in SIV-infected non-human primates
Read moreAn experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read moreNew findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for
Read moreScientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict
Read morePegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment
Read moreImmunotherapies have revolutionized the care of many cancers, teaching the body’s own immune cells to recognize and attack tumor cells.
Read moreIn a new study including Yale Cancer Center and Smilow Cancer Hospital researchers, the cancer immunotherapy drug pembrolizumab (Keytruda), increased
Read moreImmunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of
Read moreScientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of
Read more